Impact of <i>KMT2A</i> Rearrangement on Peripheral T-Cell Lymphoma, Not Otherwise Specified, and Angioimmunoblastic T-Cell Lymphoma. [PDF]
Kim TY +5 more
europepmc +1 more source
Nodal Peripheral T-Cell Lymphoma: Therapeutic Challenges and Future Perspectives. [PDF]
Lam HPJ, Amin F, Arulogun SO, Gleeson M.
europepmc +1 more source
Peripheral T-cell lymphoma with central nervous system involvement and elevated interleukin-10 levels in the cerebrospinal fluid: A case report. [PDF]
Wang X +5 more
europepmc +1 more source
Treatment patterns and survival outcomes of peripheral T-Cell lymphoma in Saudi Arabia: a 12-Year retrospective analysis. [PDF]
Al-Mansour M +7 more
europepmc +1 more source
Determination of Total and Free Plasma Concentration of Liposomal Mitoxantrone and Clinical Application in Adult Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma. [PDF]
Xu Y +6 more
europepmc +1 more source
Synergistic adverse prognostic impact of CD30 and Epstein-Barr virus in peripheral T-cell lymphoma: CD30 identifies a high-risk subgroup in Epstein-Barr virus-encoded RNA -positive patients. [PDF]
Chen ZT +12 more
europepmc +1 more source
Unusual peripheral T-cell lymphoma with a cytotoxic phenotype presenting in the pancreas. [PDF]
Dubois J +8 more
europepmc +1 more source
Effectiveness and safety profile of chidamide as maintenance therapy for peripheral T-cell lymphoma: a multicenter real-world study. [PDF]
Jiang W +6 more
europepmc +1 more source
Clinical implications of ctDNA-based minimal residual disease detection in newly diagnosed peripheral T-cell lymphoma: a single-center cohort study. [PDF]
Liang JH +17 more
europepmc +1 more source
Antibody-Based Therapies for Peripheral T-Cell Lymphoma. [PDF]
Shafagati N +3 more
europepmc +1 more source

